Rankings
▼
Calendar
TLSI Q3 2021 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$160M
Q3 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$807,259
Net Income
$2M
EPS (Diluted)
$0.06
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$365,139
Free Cash Flow
-$365,140
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$251M
Total Liabilities
$20M
Stockholders' Equity
$230M
Cash & Equivalents
$277,805
← FY 2021
All Quarters
Q4 2021 →
